# Effects of a New Combination of Nutraceuticals (AkP06) Without Monacolin K on Plasma Lipids and Glucose

> **NCT03340285** · NA · COMPLETED · sponsor: **Federico II University** · enrollment: 45 (actual)

## Conditions studied

- Cardiovascular Risk Factor

## Interventions

- **DIETARY_SUPPLEMENT:** AkP06
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03340285
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-01
- **Primary completion:** 2018-03-31
- **Final completion:** 2018-12-01
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2019-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03340285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03340285, "Effects of a New Combination of Nutraceuticals (AkP06) Without Monacolin K on Plasma Lipids and Glucose". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03340285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*